Jaundice

• 1. Introduction

  ›

  Jaundice turns skin and eyes yellow, a visible signal from the body that something has gone wrong beneath the surface. The word itself comes from the French jaunisse, meaning yellow disease, and the condition has been recognised and named across cultures for centuries. What makes it remarkable is how common it is in newborns yet how rare it is in adults, and how the same yellowing of the skin can mean something as harmless as not eating for a day or two, or something as serious as cancer. In about 80 percent of babies, jaundice appears in the first week of life. In adults, it typically flags a disease involving the liver, the blood, or the tubes that carry bile. To understand why that yellow tint appears, you have to follow a single pigment called bilirubin on its long journey through the body, and understand what happens when that journey goes wrong.

• 2. The Bilirubin Journey

  ›

  Red blood cells live for about 120 days. When they age or are damaged, they rupture as they pass through the reticuloendothelial system. The cellular contents, including hemoglobin, are released into circulation. Macrophages engulf the free hemoglobin and split it into two parts: heme and globin. From there, the heme molecule goes through a two-step chemical transformation. First, an enzyme called heme oxygenase converts it into biliverdin, a green pigment. Then a second enzyme, biliverdin reductase, reduces biliverdin into bilirubin, a yellow pigment. Around 4 mg of bilirubin per kg of blood are produced each day. Roughly 20 percent of this bilirubin comes not from expired red cells but from other sources, including muscle myoglobin and cytochromes.

  Because unconjugated bilirubin is not soluble in water, it travels through the bloodstream bound to serum albumin. When it reaches the liver, an enzyme called UDP-glucuronyl transferase attaches glucuronic acid to the bilirubin, making it water-soluble. This conjugated bilirubin is then excreted into the gallbladder. From there it enters the intestinal tract via bile, where bacteria convert it into urobilinogen. Most of that urobilinogen becomes stercobilin, the compound that gives stool its characteristic brown color. A small portion is reabsorbed and filtered into the kidneys, where it becomes urobilin, which gives urine its yellow color. When blood levels of bilirubin exceed 2-3 mg/dl, jaundice becomes visible. Normal levels sit below 1.0 mg/dl.

• 3. Three Failure Points

  ›

  Doctors organise jaundice into three categories based on where in the bilirubin pathway the breakdown occurs. Prehepatic jaundice originates before the liver gets involved. It is usually caused by an abnormally high rate of red blood cell destruction, a process called hemolysis. Conditions such as sickle-cell anemia, thalassemia, and glucose-6-phosphate dehydrogenase deficiency can all trigger this form, as can infections including malaria and bartonellosis.

  Hepatic jaundice arises from damage to the liver cells themselves. Acute and chronic hepatitis, cirrhosis, alcoholic liver disease, and certain medications can all disrupt the liver's ability to take up, conjugate, and excrete bilirubin. A notable exception to this pattern is Gilbert's syndrome, found in about 5 percent of the population. In Gilbert's syndrome, liver function is otherwise normal, but genetic variants make the UDP-glucuronyl transferase enzyme less efficient. Affected individuals typically experience mild jaundice during periods of stress, not from liver damage.

  Posthepatic jaundice, also called obstructive jaundice, results from a physical blockage of the bile ducts after conjugation has already taken place. The most common cause of this type is choledocholithiasis: gallstones lodged in the common bile duct. Other causes include pancreatic cancer of the pancreatic head, biliary atresia, and parasites known as liver flukes from the Opisthorchiidae and Fasciolidae families. When the bile duct is completely blocked, conjugated bilirubin cannot reach the intestine. No stercobilin or urobilin is produced, which explains why patients with obstructive jaundice often have pale, whitish stools and dark brown urine.

• 4. Reading the Signs

  ›

  Scleral icterus, the yellowing of the white of the eye, appears at a serum bilirubin level of at least 3 mg/dl, making it one of the earliest visible signs. The conjunctival membranes overlying the sclera have a particularly high affinity for bilirubin because of their high elastin content, so even slight rises in blood bilirubin show up there before they show clearly in the skin. In individuals with darker skin tones, the yellowing of the skin can be harder to detect, and clinicians are trained to look at the sclera, palms, soles, and oral mucosa for reliable assessment.

  A rare sign specific to childhood is the appearance of yellowish or greenish teeth. When bilirubin deposits during tooth calcification, it can stain the developing teeth permanently. This does not happen in adults who develop liver disease later in life. The same early-life bilirubin excess can also cause dental hypoplasia, a deficiency in tooth enamel.

  Itchiness is a common complaint in jaundice patients because bilirubin is a skin irritant. Pale fatty stools and dark urine round out the trio of hallmark symptoms. The exact pattern of laboratory abnormalities helps narrow the cause. In alcoholic liver damage, the enzyme AST can run more than 10 times higher than ALT. In viral or toxic hepatitis, ALT typically exceeds AST. Acetaminophen toxicity can push AST and ALT to more than 50 times their normal ceiling. Bilirubin levels greater than 10 times normal suggest neoplastic disease or severe intrahepatic cholestasis.

• 5. Newborns and the Brain

  ›

  Transient neonatal jaundice is one of the most common conditions in newborns under 28 days of age. More than 80 percent of newborns experience it in their first week of life. The underlying reason is a convergence of immature systems: liver enzymes that process bilirubin are not yet fully active, the gut microbiota is underdeveloped, and fetal hemoglobin, which is being replaced in large quantities after birth, breaks down rapidly.

  Breast milk jaundice follows a distinct mechanism. An increased concentration of beta-glucuronidase in breast milk drives extra deconjugation and reabsorption of bilirubin. Onset is typically within two weeks after birth, and the condition can persist for 4-13 weeks.

  Most cases resolve without harm. But when bilirubin levels climb high enough, unconjugated bilirubin can cross the blood-brain barrier and cause kernicterus, a form of permanent neurological damage. Newborns are especially vulnerable because the blood-brain barrier is more permeable when unconjugated bilirubin is elevated, all while fetal hemoglobin breakdown is still ongoing. Kernicterus cases have been rising in recent years, a trend linked to babies spending less time in sunlight.

  When treatment is needed, phototherapy using a bili light is the standard first step. A 2021 Cochrane review found that sunlight can supplement phototherapy, as long as overheating and skin damage are avoided, though sunlight alone did not have enough evidence behind it to be considered a standalone treatment. Exchange transfusion is reserved for more severe cases. Frequent feedings matter too, because bowel movements and urination increase bilirubin excretion.

• 6. Diagnosis and Mimics

  ›

  No single laboratory test can definitively classify jaundice. Clinicians rely on a combination of liver enzyme panels, bilirubin fractions, urine findings, and imaging. Ultrasound and CT scan with contrast are typically used first for suspected bile duct blockage because they are rapid, noninvasive, and cost-effective. When those tests point toward bile duct obstruction specifically, endoscopic retrograde cholangiopancreatography (ERCP) or magnetic resonance cholangiopancreatography (MRCP) may follow.

  Liver biopsy enters the picture only when labs and imaging cannot determine the cause. There is a substantial risk of bleeding of up to 10 percent associated with the procedure, so it is reserved for cases where the result will meaningfully change diagnosis or treatment.

  Not every yellow tint means jaundice. Carotenemia, from overconsumption of foods such as carrots, leafy vegetables, squash, peaches, and oranges, also yellows the skin. The key clinical difference is distribution: carotenemia concentrates the discoloration on the palms and soles, while true jaundice produces diffuse yellowing across the body. Carotenemia does not affect the sclera or the inside of the mouth. Certain medications, including quinacrine, sunitinib, and sorafenib, can also cause skin yellowing. Wilson's disease, a condition involving excess copper, can add a golden ring at the edge of the irises known as a Kayser-Fleischer ring alongside skin discoloration.

  In the developed world, bile duct blockage and medication-induced causes account for the most cases of adult jaundice. In the developing world, infectious diseases, including viral hepatitis, leptospirosis, schistosomiasis, and malaria, are the leading drivers.

• 7. Prevalence and Risk

  ›

  Adult jaundice is genuinely uncommon. Under the five-year DISCOVERY programme in the UK, the annual incidence was 0.74 per 1,000 individuals over the age of 45. The programme's primary focus was collecting cancer data, which may slightly inflate that figure.

  Among critically ill patients, the picture is sharply different. Up to 40 percent of patients in intensive care units experience jaundice, either as the primary reason for admission or as a complication of another condition such as sepsis.

  Mean serum total bilirubin levels differ between sexes. Men averaged 0.72 mg/dl in measured adult populations while women averaged 0.52 mg/dl. Levels also vary by ethnicity: non-Hispanic white and Mexican American populations showed higher bilirubin averages than non-Hispanic black populations. Active smokers carry higher bilirubin levels than non-smokers.

  The word icterus, the medical term for jaundice, comes from the Greek ikteros. It appears in the scientific name of the yellow-breasted chat, Icteria virens, a bird whose sight was once believed to cure the very condition it was named after.